Differential effects of cytomegalovirus infection on complement synthesis by human mesangial cells

Clinical and Experimental Immunology

Volumn 109, Issue 3, 1997, Pages 518-525

  Timmerman, J J ^a   Beersma, M F C ^a   Van Gijlswijk Janssen, D J ^a   Van Es, L A ^a   Van Der Woude, F J ^a   Daha, M R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complement; Human cytomegalovirus; Interferons; Kidney; Mesangial cells

Indexed keywords

ALPHA INTERFERON; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BETA INTERFERON; COMPLEMENT; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; GAMMA INTERFERON;

ANTIGEN EXPRESSION; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CYTOLYSIS; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMEDIATE EARLY GENE; IMMUNE SYSTEM; IMMUNOFLUORESCENCE; MESANGIUM CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030867405     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4651364.x     Document Type: Article

References (43)

1. Griffiths PD, Grundy JE. The status of CMV as a human pathogen. Epidem Infect 1992; 100:1-15.
2. Ho M. Observations from transplantation contributing to the understanding of pathogenesis of CMV infection. Transpl Proc 1991; 23: 104-9.
3. Marker SC, Howard RJ, Simmons RL et al. Cytomegalovirus infection: a quantitative prospective study of three hundred and twenty consecutive renal transplants. Surgery 1981; 89:660-71.
4. Herrera GA, Alexander RW, Cooley CF et al. Cytomegalovirus glomerulopathy: a controversial lesion. Kidney Int 1986; 29:725-33.
5. Smith RD, Wehner RW. Acute cytomegalovirus glomerulonephritis. Lab Invest 1980; 43:278-86.
6. Wehner RW, Smith RD. Progressive cytomegalovirus glomerulonephritis. Am J Pathol 1983; 112:313-25.
7. Heieren MH, van der Woude FJ, Balfour HH. Cytomegalovirus replicates efficiently in human kidney mesangial cells. Proc Natl Acad Sci USA 1988; 85:1642-6.
8. Beneck D, Greco MD, Feiner HD. Glomerulonephritis in congenital cytomegalic inclusion disease. Hum Pathol 1986; 17:1054-9.
9. van Dorp WT, van Wieringen PA, Marselis-Jonges E et al. Cytomegalovirus directly enhances MHC class I and intracellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation 1993; 55:1367-71.
10. Ustinov JA, Mattila P, Hayry P, Lautneschlager I. CMV infection in various cell types of human kidney. Transpl Proc 1992; 24:285.
11. Ustinov JA, Loginov RJ, Mattila PM et al. Cytomegalovirus infection of human kidney cells in vitro. Kidney Int 1991; 40:954-60.
12. Beersma MFC, Bijlmakers MJE, Ploegh HL. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 1993; 151:4455-64.
13. Jones TR, Hanson LK, Sun L, Slater JS, Stenberg RM, Campbell AE. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol 1995; 69:4830-41.
14. Wiertz EJHJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996; 84:769-79.
15. Grundy JE, Ayles HM, McKeating JA, Butcher RG, Griffiths PD, Poulter LW. Enhancement of class I HLA antigen expression by cytomegalovirus: role in amplification of virus infection. J Med Virol 1988; 25:483-95.
16. Steinmassl M, Hamprecht K. Double immunofluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells. Arch Virol 1994; 135:75-87.
17. Morris AG. Interferons. Immunology 1988; 1:43-45.
18. Timmerman JJ, Verweij CL, van Gijlswijk-Janssen DJ, van dor Woude FJ, van Es LA, Daha MR. Cytokine-regulated production of the major histocompatibility complex class-III-encoded complement proteins factor B and C4 by human glomerular mesangial cells. Hum Immunol 1995; 43:19-28.
19. Muller-Eberhard HJ. Molecular organization and function of the complement system. Ann Rev Biochem 1988; 57:321-47.
20. Carroll MC, Campbell RD, Bentley DR, Porter RR. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 1984; 307: 237-41.
21. Rodriguez de Cordoba S, Lublin DM, Rubinstein P, Atkinson JP. Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med 1985; 161:1189-95.
22. van den Dobbelsteen MEA, Verhasselt V, Kaashoek JGJ et al. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-γ. Clin Exp Immunol 1994; 95:173-80.
23. Brooimans RA, Hiemstra PS, van der Ark AAJ, Sim RB, van Es LA, Daha MR. Biosynthesis of complement factor H by human umbilical vein endothelial cells: regulation by T cell growth factor and IFNγ. J Immunol 1989; 142:2024-30.
24. Mazeron MC, Colinon R, Roseto R, Perol Y. Detection of cytomegaloviremia using monoclonal antibodies. Develop Biol Stand 1984; 57:287-91.
25. Ripoche J, Day AJ, Harris TJR, Sim RB. The complete amino acid sequence of human complement factor H. Biochem J 1988; 249:593-602.
26. Raap AK, van de Rijke FM, Dirks RW, Sol CJ, Boom R, van der Ploeg M. Bicolor fluorescence in situ hybridization to intron and exon mRNA sequences. Exp Cell Res 1991; 197:319-22.
27. Morley BJ, Camphell RD. Internal homologies of the Ba fragment from human complement component factor B, a class III MHC antigen. EMBO J 1984; 3:153-7.
28. Belt KT, Carroll MC, Porter RR. The structural basis of multiple forms of human complement component C4. Cell 1984; 36:907-14.
29. Stinski MF. Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J Virol 1977; 23:751-67.
30. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Press, 1982.
31. Bentley DR. Primary structure of human complement component C2. Biochem J 1986; 239:339-45.
32. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res 1984; 12:1687-96.
33. Beaucage SL, Caruthers MH. Deoxynucleoside phosphoramidites, a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett 1981; 22:1859-62.
34. Saiki RK. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1987; 239:487-91.
35. Timmerman JJ, van der Woude FJ, van Gijlswijk-Janssen DJ, Verweij CL, van Es LA, Daha MR. Differential expression of complement components in human fetal and adult kidneys. Kidney Int 1996; 49:730-40.
36. Crumpacker CS. Mechanism of action of foscarnet against viral polymerases. Am J Med 1992; 92:3S-7S.
37. Frey J, Einsfelder B. Induction of surface IgG receptors in cytomegalovirus-infected human fibroblasts. Eur J Biochem 1983; 138:214-6.
38. Xu-bin, Murayama T, Ishida K, Furukawa T. Characterization of IgG Fc receptors induced by human cytomegalovirus. J Gen Virol 1989; 70:893-900.
39. Cooper NR, Nemerow GR. Complement, viruses, and virus-infected cells. Springer Semin Immunopathol 1983; 6:327-47.
40. Mayes JT, Nemerow GR, Cooper NR. Alternative pathway activation by Epstein-Barr virus infected normal B lymphocytes. Fed Proc 1983; 42:5530.
41. Nemerow GR, Cooper NR. Isolation of Epstein-Barr virus and studies of its neutralization by human IgG and complement. J Immunol 1981; 127:272.
42. Spiller OB, Morgan BP, Tufaro F, Devine DV. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur J Immunol 1996; 26:1532-8.
43. Hourcade D, Holers M, Atkinson JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989; 45:381-416.